Leerink Partnrs Has Optimistic Outlook of Pfizer Q2 Earnings
Pfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs boosted their Q2 2025 earnings estimates for Pfizer in a research report issued on Wednesday, April 30th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will post earnings of $0.57 per share for the quarter, up from their prior forecast […]
Pfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Leerink Partnrs boosted their Q2 2025 earnings estimates for Pfizer in a research report issued on Wednesday, April 30th. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will post earnings of $0.57 per share for the quarter, up from their prior forecast […]
